Search

Your search keyword '"Fallai, C."' showing total 86 results

Search Constraints

Start Over You searched for: Author "Fallai, C." Remove constraint Author: "Fallai, C." Database Unpaywall Remove constraint Database: Unpaywall
86 results on '"Fallai, C."'

Search Results

1. Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis

2. PH-0043: Age related toxicity and outcome in oropharyngeal and nasoparyngeal cancer patients

4. PO-1577: Baseline MRI-radiomics can predict overall survival in non endemic nasopharyngeal cancer patients

6. PO-1798: Quality of radiotherapy treatment plans for locally advanced sinonasal tumors in a phase II trial

7. PD-0545: Validation of a predictive model for salivary dysfunction during chemo-IMRT for head-neck cancer

8. COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy

10. Introducing Information on Saliva Microbiota into Toxicity Modeling: Preliminary Results from a Trial

12. EP-1190 Preliminary evaluation of salivary cytokines in patients treated with IMRT for head and neck cancer

15. PO-160 Tumor and retropharyngeal nodal GTVs prognostic role in unresectable non-glandular sinonasal cancers

16. PO-112 Role of microbiota in predicting oral mucositis in head and neck cancer patients treated with IMRT

20. Combination of brain radiotherapy (RT) and immunotherapy (IT) in a single Institution cohort of patients (pts) with metastatic melanoma (MM)

21. Study of the correlation between rectal wall in vivo dosimetry performed with MOSkins and implant modification during TRUS-guided HDR prostate brachytherapy

22. Prognostic Value of Metabolic Parameters by 18 F-FDG PET/CT in Nasopharyngeal Cancer (NPC) in Non-Endemic Area

24. Association Between Toxicity Profiles During Radiation Therapy (RT) for Oropharyngeal Cancer and CBCT-Derived and Dosimetric Factors to Evaluate Global Toxicity During RT for Oropharyngeal Cancer

25. Subsite-dependent prognostic impact of age in patients with nasopharyngeal and oropharyngeal cancer

26. Clinical application of MOSkin dosimeters to rectal wall in vivo dosimetry in gynecological HDR brachytherapy

29. PD-034: Subsite-dependent prognostic impact of age in patients with nasopharyngeal and oropharyngeal cancer

30. Dissecting heterogeneity and molecular mechanisms involved in paranasal sinus cancer

31. Role of induction chemotherapy in the multimodal management of locally advanced epithelial sinonasal cancer: a single center experience

32. Clinical application of MOSkin dosimeters to rectal wall in vivo doismetry in gynecological and prostate HDR brachytherapy

33. Individual patient data meta-analysis of the impact of treatment expertise on the outcome of head and neck cancer patients treated within 6 randomized trials

37. EP-1080: Definitive or adjuvant IMRT for locally advanced sinonasal tumors: outcome and prognostic factors

38. Development and application of a trans-rectal US probe integrated with MOSkin dosimeters: In vivo rectal wall measurements during HDR prostate brachytherapy

39. OC-0175: In vivo rectal dose measures compared to planned and reconstructed doses in US-based HDR prostate brachytherapy

41. Italian version of the M.D. Anderson Symptom Inventory—Head and Neck Module: linguistic validation

43. Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis

Catalog

Books, media, physical & digital resources